Dendreon Corporation Earnings Conference Call (Q4 2013) Today's Calls 
Visit the TF Network Sites
Visit the TF Network Sites
· Corporate IR Center
· Institutional Investor Center
· Individual Investor Center
Download Plug-In
Real Player 8 Basic
Windows Media Player
Other Conference Calls
Other Mar 3 Calls
Today's Calls
Call Details
Dendreon Corporation Earnings Conference Call (Q4 2013)
Scheduled to start Mon, Mar 3, 2014, 9:00 am Eastern

This event is scheduled to be ongoing now.
However, we don't yet have information on the audio stream.

About Dendreon Corp (NasdaqGS:DNDN)
Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Its product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers. The company offers PROVENGE, an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic, metastatic, and castrate-resistant prostate cancer. Its product candidates under development comprise DN24-02, an investigational cellular immunotherapy, which is in Phase II clinical trials for the treatment of patients with bladder, breast, ovarian, and other solid tumors expressing HER2/neu; and carbonic anhydrase 9, an antigen expressed in renal cell carcinoma that is in preclinical development. The company is also developing carcinoembryonic antigen, an antigen in preclinical development, which is expressed in colorectal and other cancers; and Transient Receptor Potential, sub-family M 8, a small molecule that has completed Phase I clinical trial to treat multiple cancers. Dendreon Corporation was founded in 1992 and is headquartered in Seattle, Washington.


More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings


Copyright © 2014 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Copyright © 2014 FirstCall Events. Historical chart data provided by Commodity Systems, Inc. (CSI). Company profile information presented on this page is Copyright Capital IQ. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.